The progressive intercontinental spread of methicillin-resistant staphylococcus aureus

Clinical Infectious Diseases

Volumn 24, Issue 1 SUPPL., 1997, Pages

  Ayliffe, G A J ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; KANAMYCIN; METICILLIN; PENICILLIN DERIVATIVE; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; EPIDEMIC; IRELAND; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UNITED STATES;

HUMANS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; WORLD HEALTH;

EID: 0031021303     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.supplement_1.s74     Document Type: Article

References (5)

1. Wenzel RP, Nettleman MD, Jones RN, Pfaller MA. Methicillin-resistant Staphylococcus aureus: implications for the 1990's and effective control measures. Am J Med 1991;91(suppl 3B):221S-7S.
2. Duckworth GJ. Diagnosis and management of methicillin résistant Staphylococcus aureus infection. BMJ 1993;307:1049-52.
3. Casewell MW. Epidemiology and control of the 'modern' methicillin-resistant Staphyloccus aureus. J Hosp Infect 1986;7(suppl A):1-11.
4. Jevons MP. "Celbenin"-resistant staphylococci. BMJ 1961;1:124-5.
5. Barber M. Methicillin-resistant staphylococci. J Clin Pathol 1961;14:385-93.